phenyl-n-tert-butylnitrone and Autoimmune Diabetes

phenyl-n-tert-butylnitrone has been researched along with Autoimmune Diabetes in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (50.00)18.2507
2000's2 (33.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cui, WG; Hu, P; Hu, ZY; Lu, Q; Ma, L; Mei, QY; Xu, DY; Zhao, Q; Zhao, X; Zhou, DS; Zhou, WH1
Floyd, RA; Jacob, JM; Kotake, Y; Tabatabaie, T; Wallis, G1
Bray, TM; Chen, G; Ho, E2
Iovino, G; Kubow, S; Marliss, EB1
Floyd, RA; Graham, KL; Kotake, Y; Tabatabaie, T; Vasquez, AM1

Other Studies

6 other study(ies) available for phenyl-n-tert-butylnitrone and Autoimmune Diabetes

ArticleYear
Secoisolariciresinol diglycoside, a flaxseed lignan, exerts analgesic effects in a mouse model of type 1 diabetes: Engagement of antioxidant mechanism.
    European journal of pharmacology, 2015, Nov-15, Volume: 767

    Topics: Analgesics; Animals; Antioxidants; Butylene Glycols; Cyclic N-Oxides; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Flax; Glycosides; Hyperalgesia; Lignans; Male; Mice; Neuralgia; Sciatic Nerve; Spinal Cord; tert-Butylhydroperoxide

2015
Spin trapping agent phenyl N-tert-butylnitrone protects against the onset of drug-induced insulin-dependent diabetes mellitus.
    FEBS letters, 1997, Apr-28, Volume: 407, Issue:2

    Topics: Animals; Cyclic N-Oxides; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Electron Spin Resonance Spectroscopy; Glycated Hemoglobin; Hyperglycemia; Islets of Langerhans; Male; Mice; Mice, Inbred BALB C; Nitrogen Oxides; Spin Trapping; Streptozocin; Weight Loss

1997
Supplementation of N-acetylcysteine inhibits NFkappaB activation and protects against alloxan-induced diabetes in CD-1 mice.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 1999, Volume: 13, Issue:13

    Topics: Acetylcysteine; Administration, Oral; Alloxan; Animals; Blood Glucose; Cyclic N-Oxides; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Electron Spin Resonance Spectroscopy; Free Radicals; Glutathione; Male; Mice; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrogen Oxides; Pancreas

1999
Effect of alpha-phenyl-N-tert-butylnitrone on diabetes and lipid peroxidation in BB rats.
    Canadian journal of physiology and pharmacology, 1999, Volume: 77, Issue:3

    Topics: Animals; Cyclic N-Oxides; Diabetes Mellitus, Type 1; Female; Glucose Tolerance Test; Lipid Peroxidation; Male; Malondialdehyde; Nitrogen Oxides; Pancreas; Rats; Rats, Inbred BB; Spin Labels

1999
Alpha-phenyl-tert-butylnitrone (PBN) inhibits NFkappaB activation offering protection against chemically induced diabetes.
    Free radical biology & medicine, 2000, Feb-15, Volume: 28, Issue:4

    Topics: Alloxan; Animals; Cyclic N-Oxides; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Free Radicals; Hyperglycemia; Islets of Langerhans; Male; Mice; NF-kappa B; Nitrogen Oxides; Reactive Oxygen Species; Spin Labels; Streptozocin

2000
Inhibition of the cytokine-mediated inducible nitric oxide synthase expression in rat insulinoma cells by phenyl N-tert-butylnitrone.
    Nitric oxide : biology and chemistry, 2000, Volume: 4, Issue:2

    Topics: Acetylcysteine; Animals; Blotting, Northern; Cell Survival; Cyclic N-Oxides; Cytokines; Diabetes Mellitus, Type 1; Enzyme Induction; Enzyme Inhibitors; Free Radical Scavengers; Immunoblotting; Insulinoma; Mice; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Nitrogen Oxides; Protective Agents; Rats; RNA, Messenger; Thioctic Acid; Tumor Cells, Cultured

2000
chemdatabank.com